Wikipedia -WSS

Wikipedia

author：fashion 2025-10-02 23:45:28 - browse：42

Zepbound, a injectable drug on a gradient background of dark purple and green — biotech coverage from STAT — Illustration: STAT; Source: Eli Lilly/AP

Eli Lilly’s blockbuster diabetes and obesity drug improved living scarring in a mid-stage study of the liver disease MASH, adding to positive data announced earlier this year.

The study tested three doses of tirzepatide, sold commercially as Mounjaro or Zepbound. The percentage of patients who experienced a greater than one-stage improvement in scarring, or fibrosis, without worsening of their disease was 54.9%, 51.3%, and 51.0% from the lowest to highest doses.

When compared with the 29.7% of patients on placebo who achieved this outcome, the results were statistically significant, according to an abstract of data that will be presented at the annual meeting of the European Association for the Study of the Liver.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： ALS groups 'won't be played again' by the FDA, drug sponsors

focus

WSS

Biotech companies concerned about China biosecurity crackdown

People with substance use disorder deserve online privacy

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Information blocking fines are now fair game in health care

Obesity now affects over 1 billion people worldwide, study finds

Midwives could help bridge maternal health disparities in the U.S.

Wikipedia

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Medical records are filled with copy

Why getting cancer drugs just got harder for rural patients

23andMe had bad news about my health. I wish a person had delivered it

Why the drug industry's warnings on the IRA's impact fall short

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

The struggle to figure out which patients 'deserve' Wegovy

Novavax promises a turnaround & Lilly roils the obesity market

White House Covid adviser calls on docs to combat misinformation

As demand for Covid shots wanes, Moderna seeks its next success

Information blocking fines are now fair game in health care

Wikipedia

Covid isolation guidance eased by the CDC

Biotech companies concerned about China biosecurity crackdown

Information blocking fines are now fair game in health care

Change Healthcare cyberattack outage could last weeks

David Liu startup to focus on CRISPR delivery

Transgender sports debate: Physicians say bans are health issue

focus

explore

focus

focus